The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Share News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SMALL-CAP WINNERS & LOSERS: MGC Pharma drops on restructuring plan

Tue, 26th Sep 2023 09:52

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.

----------

SMALL-CAP - WINNERS

----------

Synthomer PLC, 805.81 pence, multiplied from 40.30p, 12-month range 40.76-898.56p. The chemicals company announces that, following the approval of a capital reorganisation at a general meeting, 23.4 million of its shares have been admitted to trading on the London Stock Exchange. Explains that, as part of the capital organisation, its existing shares have been consolidated so that shareholders will receive consolidated shares on a ratio of 1 consolidated share in substitution for every 20 existing shares.

----------

SMALL-CAP - LOSERS

----------

MGC Pharmaceuticals Ltd, down 48% at 0.055 pence, 12-month range 0.050-0.98p. The pharmaceutical company says it finds itself at a "critical financial juncture" due to "underwhelming" fundraising efforts and the failure of its share price to appreciate. As a result, says it has been forced to design a restructuring plan to secure long-term financing. Says the plan will reduce its reliance on "constant" capital raising and allow it to complete an 18-month work plan. "We understand this restructure will be difficult for many shareholders. However, in light of dire alternatives, the board and management believe this is a necessary action to help to sustain the company's future and financial security beyond the short to immediate term," Managing Director Roby Zomer says.

----------

Videndum PLC, down 28% at 394.27 pence, 12-month range 385.00-1,360.00p. The hardware product and software solutions provider reports a sharp drop in profit in the first half of 2023 amid a number of ongoing macroeconomic headwinds. In the six months ended June 30, Videndum reports a pretax profit of GBP3.1 million, down sharply from GBP22.9 million the year prior. Revenue in the half falls to GBP165.0 million from GBP219.4 million. Company blames the drop in profit on ongoing macroeconomic headwinds, the effects of destocking the writers' strike in the US. Adds that given the ongoing strikes in the US, there will be no interim dividend. Plans to resume dividend payments "when appropriate." Looking forward, says there is a "wide range" of potential outcomes for the full-year due to the strikes and thus is unable to provide financial guidance. Separately, Videndum announces that Chair Ian McHoul will not stand for re-election at the company's 2024 annual general meeting. The search for his replacement begins.

----------

Card Factory PLC, down 5.3% at 105.28 pence, 12-month range 40.21-117.00p. The greeting card retailer says that in the six months ended July 31, pretax profit rises to GBP24.7 million from GBP14.3 million the year prior. Revenue climbs to GBP220.8 million from GBP198.0 million. Less positively, cost of sales rise to GBP139.5 million from GBP132.2 million and operating expenses rise to GBP53.2 million from GBP45.8 million. Card Factory says it is "confident" in delivering a good outturn for the year following the strength of its first half performance. Notes that trading since August has been in line with its expectations.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 Feb 2023 11:01

MGC receives USD600,000 funding; changes chief financial officer

(Alliance News) - MGC Pharmaceuticals Ltd on Friday said it received USD600,000 in funding provided by Mercer Street Capital Partners LLC, while it has appointed a new chief financial officer.

Read more
2 Feb 2023 19:39

TRADING UPDATES: Lords sells business; Atome wins joint venture deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
30 Jan 2023 16:23

TRADING UPDATES: DP Eurasia annual sales grow despite Russia decline

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
11 Jan 2023 09:30

CORRECT: Getech signs deal; AfriTin confirms name change

(Corrects that Zenith Energy is based in Canada, not in Scotland.)

Read more
10 Jan 2023 21:34

TRADING UPDATES: Getech signs deal; AfriTin confirms name change

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
3 Jan 2023 17:17

TRADING UPDATES: MGC cuts costs; Ince gets Arden sale green light

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
28 Dec 2022 09:45

IN BRIEF: MGC Pharma receives AUD800,000 funding from Mercer Street

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Secures AUD800,000 in funding under USD10 million convertible securities financing facility agreement signed with Mercer Street Global Opportunity Fund LLC, a fund managed by Mercer Street Capital Partners. Under the terms of the facility, MGC will issue Mercer 586,432 convertible notes with a face value of USD1.0 each. The company said the funding will be used as working capital for "ongoing operations", including its clinical trials programme.

Read more
5 Dec 2022 14:09

IN BRIEF: MGC Pharmaceuticals delivers USD1 million order of ArtemiC

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Completes the delivery of its "largest" order of ArtemiC Rescue to US distribution and marketing partner, AMC Holdings Inc. Says the order is worth USD1.0 million and was delivered in a single shipment.

Read more
17 Nov 2022 15:48

UK shareholder meetings calendar - next 7 days

Friday 18 November 
MJ Gleeson PLCAGM
Just Eat Takeaway.com N.V.EGM
Marula Mining PLCAGM
NIOX Group PLCGM share premium account cancellation
Sovereign Metals LtdAGM
Monday 21 November 
Manchester & London Investment Trust PLCAGM
Mountview Estates PLCGM re re-electing Chair Powell, non-exec Archibald
RPS Group PLCGM cash offer agreement
Yamana Gold IncGM Gold Fields offer
Tuesday 22 November 
Alpha FX Group PLCGM re name change
Artemis Resources LtdAGM
Fonix Mobile PLCAGM
Kingswood Holdings LtdAGM
Origin Enterprises PLCAGM
Physiomics PLCAGM
Quantum Exponential Group PLCAGM
Rainbow Rare Earths LtdAGM
Sabien Technology Group PLCAGM
Town Centre Securities PLCAGM
Wednesday 23 November 
Crystal Amber Fund LtdAGM
CVS Group PLCAGM
Fidelity Asian Values PLCAGM
Genus PLCAGM
JPMorgan Russian Securities PLCGM re name change
Synergia Energy LtdAGM
Wilmington PLCAGM
Woolworths Holdings LtdAGM
Thursday 24 November 
Cloudbreak Discovery PLCAGM
EnSilica PLCAGM
Fiske PLCAGM
MGC Pharmaceuticals LimitedAGM
Pacific Horizon Investment Trust PLCAGM
Pan African Resources PLCAGM
PZ Cussons PLCAGM
Zanaga Iron Ore Co LtdAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
25 Oct 2022 14:53

TRADING UPDATES: Gunsynd invests; AQRU launches crypto-backed loans

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
4 Oct 2022 11:07

IN BRIEF: MGC Pharmaceuticals appoints Yifat Steuer deputy CEO

MGC Pharmaceuticals - Perth, Australia-based medicinal cannabis company - Appoints Yifat Steuer as the company's new chief operating officer and deputy chief executive officer. Steuer has worked across a range of pharmaceutical companies, including Johnson & Johnson, GSK PLC as well as with start-ups. The company said that Brett Mitchell has moved from executive chair to non-executive chair "to be more in line with corporate structuring of UK listed companies."

Read more
28 Sep 2022 16:05

UK shareholder meetings calendar - next 7 days

Thursday 29 September 
ActiveOps PLCAGM
Chill Brands Group PLCAGM
Coral Products PLCAGM
Echo Energy PLCGM re approval of annual report
Jaywing PLCGM re funding
Orient Telecoms PLCAGM
President Energy PLCGM proposed capital reorganisation
Samarkand Group PLCAGM
TransGlobe Energy CorpGM re merger with Vaalco Energy Inc
Ted Baker PLCGM re shareholders vote on acquisition by ABG 
Vaalco Energy IncGM re merger with TransGlobe Energy Corp
Van Elle Holdings PLCAGM
Walker Crips Group PLCAGM
Friday 30 September 
Capital Metals PLCAGM
Henderson Smaller Companies Investment Trust PLCAGM
Ince Group PLCAGM
Indivior PLCGM additional US listing
Insig AI PLCGM financial outcomes
Libertine Holdings PLCAGM
MiLOC Group LtdAGM
Oakley Capital Investments LtdAGM
OptareAGM
Pennpetro Energy PLCAGM
Saietta Group PLCAGM
TMT Acquisition PLCAGM
TPXimpact Holdings PLCAGM
Versarien PLCAGM
Monday 3 October 
Jupiter Emerging & Frontier Income Trust PLCGM re amending redemption facility
Kape Technologies PLCGM re fundraise
Tuesday 4 October 
Henderson Diversified Income TrustAGM
Wednesday 5 October 
Goodwin PLCAGM
Hambro Perks Acquisition Co LtdAGM
MGC Pharmaceuticals LtdGM convertible securities agreement
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
28 Sep 2022 12:23

MGC Pharmaceuticals shares down on advertising fine in Australia

(Alliance News) - MGC Pharmaceuticals Ltd on Wednesday said it faces 23 infringement notices worth AUD306,960, around GBP185,470, for contravening therapeutic goods advertising laws.

Read more
23 Sep 2022 13:43

IN BRIEF: MGC Pharma receives USD550,000 more from Mercer Street

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Receives a further USD550,000 under the USD10 million financing agreement signed with Mercer Street Global Opportunity Fund LLC, a fund managed by Mercer Street Capital Partner. Under the terms of the agreement, announced in July, MGC Pharma will now issue Mercer 605,000 convertible notes with a face value of USD1.00 each. The funds received will be used to fund MGC's ongoing operations such as clinical trials.

Read more
21 Sep 2022 17:53

IN BRIEF: MGC notes "encouraging" results from CimetrA study

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says interim results from the CimetrA study show no significant Covid-19 related complications, compared to 63% of placebo group who reported adverse events related to Covid-19 symptoms. The study had 16 participants with Covid-19. No patients from either drug study group showed any Covid-19 related adverse events, it noted. It also notes improvements in multiple parameters measuring the patient's clinical condition, such as respiratory rate and oxygen saturation, when compared to placebo.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.